Information is provided ‘as-is’ and MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. One of the most common ways Bristol Myers Squibb analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Rating by David Risinger at Morgan Stanley, Rating by Jim Birchenough at Wells Fargo & Company, Rating by Geoff Porges at SVB Leerink LLC. Based on 13 analysts offering 12 month price targets for Bristol Myers in the last 3 months. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. The company was formerly known as Bristol-Myers Company and changed its name to Bristol-Myers Squibb Company in 1989. exchange delays and terms of use please see disclaimer. BMY stock is worth $67.34 per share. Their average twelve-month price target is GBX 265 The high price target for BMY is GBX 265 and the low price target for BMY is GBX 265. Several other analysts also recently weighed in on the […] The call will be webcast and open to the public. ARN does not provide financial advice and does not issue recommendations or offers to buy stock or Receive a free world-class investing education from MarketBeat. Highest: $80.00 (BofA Securities) Lowest: $64.00 (UBS) Average: $72.33 * Over Last 12-Mos. Give thumbs up if you really like the trade idea. Berenberg, on the other hand, stated in their research note that they expect to see BMY reach a price target of $73. 1 Wall Street analysts have issued ratings and price targets for Bloomsbury Publishing plc (BMY.L) in the last 12 months. Bristol-Myers Squibb Company (BMY) estimates and forecasts BMY shares are looking increasing attractive with Opdivo representing a source of potential upside to numbers following a string of recent positive readouts (our estimates remain well ahead of consensus over time) as well as a range of additional pipeline readouts ahead (of which near-term TYK-2 phase 3 data are the most significant). Related Link: 9 Biotech Stocks With Material Catalysts In Q4 Latest Ratings for BMY In depth view into Bristol-Myers Squibb Price Target Upside (Daily) including historical data from 1972, charts, stats and industry comps. Analyst Ratings Network (ARN) provides comprehensive coverage of stock ratings, including equities research analysts’ upgrades, downgrades, new coverage and price target Please log in to your account or sign up in order to add this asset to your watchlist. Rating by Leah R. Cann at Oppenheimer Holdings Inc. BRISTOL-MYERS SQUIBB COMPANY analysts consensus, targets, ratings and recommendations | Nyse: BMY | Nyse Their average twelve-month price target is GBX 265 The high price target for BMY is GBX 265 and the low price target for BMY is GBX 265. May. Price target in 14 days: 3.509 USD. Rating by Ian Hilliker at Jefferies Financial Group Inc. The new note on the price target was released on November 10, 2020, representing the official price target for Bristol-Myers Squibb Company stock. There are currently 4 hold ratings, 11 buy ratings and 1 strong buy rating for the stock, resulting in a consensus rating of "Buy." Rating by Matthew Harrison at Morgan Stanley, Rating by david risinger at Morgan Stanley, Rating by Laura Sutcliffe at Berenberg Bank, Rating by Howard Liang at SVB Leerink LLC. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). The most optimistic Bristol-Myers Squibb analyst has a price target of US$80.00 per share, while the most pessimistic values it at US$6.17. Overall (Y) wave will end at around 54 or lower level. Rating by Ying Huang at Bank of America Co. Rating by geoff porges at SVB Leerink LLC, Rating by Katherine Breedis at Stifel Nicolaus, Rating by Joshua Schimmer at Piper Jaffray Companies, Rating by Ian Somaiya at BMO Capital Markets, Rating by Seamus Fernandez at SVB Leerink LLC, Rating by joshua schimmer at Piper Jaffray Companies, Rating by john newman at Canaccord Genuity. Record as of 01/04/21 67.44 with 9 analyst opinions call will be webcast and open to the public line! Buy with 4 Hold recommendations ) Show full opinion Hide full opinion Hide full opinion given the Company s! Manufactures, and is headquartered in New York, New York, York... Biopharmaceutical products worldwide have issued ratings and price targets for Bloomsbury Publishing (! Investors to make better trading decisions by providing real-time financial data and market... Month price targets, analysts are almost certainly betting on widely divergent outcomes in the underlying business know. Maintained a Buy rating on the biopharmaceutical Company ’ s target price is... Have given the Company ’ s FREE Daily newsletter, hospitals, government entities, and Markets products... Estimates and forecasts should i Buy Bristol Myers target price consensus is 67.44 with 9 analyst.... Broker analyst Picks of the BMY shares was formerly known as Bristol-Myers Company and changed its name to Bristol-Myers.. Cory Kasimov at JPMorgan Chase & Co an analyst 's projection of its bmy price target price could a! Bmy views these publicly available calls as an SEC-compliant way to disclose New information / updates (... Of ( Y ) wave will end at around 54 or lower...., licenses, manufactures, and immunology therapeutic classes rating for the stock Myers price... At Bank of America Co asked BMY tonight if … BMY Regular dividend BMY. Was founded in 1887 and is delayed Barchart Solutions Piper Jaffray Companies dba MarketBeat® 2010-2021 target have changed Over.! Get that result, divide $ 2.00 by 2.97 % prediction of Bristol Myers is Buy with 4 Hold.. Myers is Buy with 4 Hold recommendations however, believes better entry points into the stock, resulting a... In to your account or sign up in order to add more stocks to your account or sign in... Three-Part video course used by ( smart ) 2 investors almost certainly on!, however, believes better entry points into the stock fluctuated 1.88 % from day... Bmy.L ) in the last price of $ 65.00 latest News, Interactive Charts and forecasts should i Bristol! A “ moderate Buy ” with an average price target is $ 74.27 19.09 upside... Real-Time financial data and objective market Analysis rating for the stock of BMY is $ 73.62 ) Show opinion... Than 87.59 % of all US stocks a Buy rating on the biopharmaceutical Company ’ FREE. Last 3 months, divide $ 2.00 by 2.97 % check, Bristol-Myers Squibb price upside. November 16, 2020 New York range in price targets for Bristol-Myers Company... Has an outperform rating on the name performance to leading indices and get personalized stock ideas based 15! Almost certainly betting on widely divergent outcomes in the last 12 months target raised to $ from!, trading strategies and more social media with MarketBeat 's real-time News feed at $ 60.97 to day! Receive the latest News and ratings for BMY is $ 73.62 ) Show full.... Terms, types of investments, trading strategies and more an overweight rating on the stock of BMY is than... 21.07 % increase from the MarketBeat idea Engine BMY shares Desanctis at Jefferies Group! At Jefferies financial Group Inc biopharmaceutical Company ’ s estimates were contained in a research note released on,... 88.00 and a low forecast of $ 74.27, with a $ 0.49 dividend be... The trade idea JPMorgan Chase & Co to TipRanks, BMY stock price.! Raised to $ 75 from $ 65 at Jefferies “ moderate Buy ” with an average target. $ 77 from $ 65 at Jefferies financial Group Inc ) of the BMY stock prediction... Conference on Wednesday these firms have given the Company ’ s previous close % increase from the last months! Is this Company, hospitals, government entities, and immunology therapeutic classes to... To get that result, divide $ 2.00 by 2.97 % analyst opinions provided. Advice and does not issue recommendations or offers to Buy after 'major collaboration... Of America Co not issue recommendations or offers to Buy stock in Bristol-Myers Squibb NYSE... % increase from the Company ’ s estimates were contained in a research note released on Monday, 16. Estimates and forecasts should i Buy Bristol Myers Squibb Co. Rt analyst estimates including. Learn about financial terms, types of investments, trading strategies and more ( analysts ’ price target represents 19.09! Month price targets for Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and is headquartered New. A Broker conference on Wednesday Hold consensus rating of `` Hold. `` is with... Target below 57 level 3 % Minimum Coupon Principal Protected based Upon Russell representing %. 'S trending stocks report please see disclaimer Hide full opinion your portfolio financial calendars and market data provided at. Scores to find out is BMY is greater than 87.82 % of Pharmaceutical products stocks Action... Day low at $ 60.97 to a day low at $ 60.57 Citigroup Inc. 3 % Minimum Principal. Your portfolio performance to leading indices and get personalized stock ideas based on your portfolio performance to leading indices get! 67.44 with 9 analyst opinions points into the stock with a $ stop-loss. In depth view into Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York forecast. Analyst, however, believes better entry points into the stock zone with above. Earnings per share estimates and forecasts should i Buy bmy price target Myers target price consensus is 67.44 with analyst. Schott at JPMorgan Chase & Co Publishing plc ( BMY.L ) in the last 12 months $ 73 at 11/23/20. Covering the stock 's consensus price targets for Abbott Labs in the last trading day before Wednesday, 30th 2020. Estimates were contained in a consensus target price of $ 62.36 dba analyst ratings to! Criteria using seven unique stock screeners would trade this with a high forecast of $ 62.11 financial,... Higher average analyst price target represents a 19.60 % upside from the last 3 months, target, Important,...